申请人:The Procter & Gamble Company
                            
                            
                                公开号:US20040167183A1
                            
                            
                                公开(公告)日:2004-08-26
                            
                            Compounds of formula (I):
1
are effective in the treatment of protein tyrosine phosphatase (PTPase) mediated disorders such as diabetes.
                            公式(I)的化合物在治疗蛋白
酪氨酸磷酸酶(
PTPase)介导的疾病,如糖尿病方面具有有效性。